Matthew Flick: New Evidence on SARS-CoV-2 Spike Protein and Clot Formation
Matthew Flick, Professor at University of North Carolina at Chapel Hill, shared on LinkedIn about a recent article he and his colleagues co-authored, adding:
”I’m excited to report that our latest publication is now available online in Blood Advances – Blood Journals Portfolio.
Here we provide data supporting the idea that the SARS-CoV-2 spike protein conditionally binds fibrin(ogen), but we refute the concept that it influences plasma clot fibrin formation, structure, or lysis.
Outstanding work by lead author Kadri Kangro. Another amazing collaboration with my colleague Alisa Wolberg and her team, namely Samer Issa.”
Title: SARS-CoV-2 spike protein can bind fibrin(ogen), but does not alter plasma fibrin formation, clot structure, or lysis
Authors: Kadri Kangro, Samer M Issa, Alisa S. Wolberg, Matthew J. Flick
Read the Full Article on Blood Advances
Stay updated with Hemostasis Today.
-
Mar 26, 2026, 15:39Fabrice Cognasse: Platelets May Play a Much Broader Role in Regulating Inflammation
-
Mar 26, 2026, 15:27Maxime Dely: Anticoagulant Is an Invisible Yet Essential Ally of Therapeutic Apheresis
-
Mar 26, 2026, 15:24Colleen Silk: Fueling Innovation in Rare Bleeding Disorders at THSNA 2026
-
Mar 26, 2026, 15:19Wolfgang Miesbach: A Remarkable Progress With Non-Factor Therapies in Hemophilia Care
-
Mar 26, 2026, 15:19Attilio Cotroneo: Updated Evidence-Based Recommendations for the Management of BTAI
-
Mar 26, 2026, 15:14Rodrigo Assar: Thrombosis Risk Prediction in Pediatric Central Lines
-
Mar 26, 2026, 14:48Alfonso J. Tafur: We Need to Rethink What Drives Disparities in Blood Clot Outcomes
-
Mar 25, 2026, 16:00Randa Bascharon: When to Consider Wharton’s Jelly in Tendon, Ligament, and Joint Conditions
-
Mar 25, 2026, 15:56Boris Pasche: Karmanos Cancer Institute Leads Innovation in Cancer and Hematologic Disease Treatment